Read More Pharma Industry News AstraZeneca’s Forxiga wins approval in China for heart failure treatment AstraZeneca has announced that its drug, Forxiga (dapagliflozin), has received approval from the Chinese National Medical Products Administration… bypharmanewsdailyFebruary 7, 2021
